Literature DB >> 7475776

Variation in protection by BCG: implications of and for heterologous immunity.

P E Fine1.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7475776     DOI： 10.1016/s0140-6736(95)92348-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  431 in total

1.  Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6.

Authors:  A Weinrich Olsen; L A van Pinxteren; L Meng Okkels; P Birk Rasmussen; P Andersen
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

Review 2.  Vaccine trials.

Authors:  C P Farrington; E Miller
Journal:  Mol Biotechnol       Date:  2001-01       Impact factor: 2.695

Review 3.  Effective vaccination against tuberculosis-a new ray of hope.

Authors:  J M Grange
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

4.  Mycobacterium tuberculosis-secreted protein antigens: immunogenicity in baboons.

Authors:  K Pehler; K M Brasky; T M Butler; R Attanasio
Journal:  J Clin Immunol       Date:  2000-07       Impact factor: 8.317

5.  Genetic regulation of acquired immune responses to antigens of Mycobacterium tuberculosis: a study of twins in West Africa.

Authors:  A Jepson; A Fowler; W Banya; M Singh; S Bennett; H Whittle; A V Hill
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

Review 6.  BCG and tuberculosis.

Authors:  M J Bannon
Journal:  Arch Dis Child       Date:  1999-01       Impact factor: 3.791

7.  Modulation of a heterologous immune response by the products of Ascaris suum.

Authors:  Jacqueline C M Paterson; Paul Garside; Malcolm W Kennedy; Catherine E Lawrence
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

8.  Immunogenicity and protection induced by a Mycobacterium tuberculosis sigE mutant in a BALB/c mouse model of progressive pulmonary tuberculosis.

Authors:  Rogelio Hernandez Pando; Leon Diana Aguilar; Issar Smith; Riccardo Manganelli
Journal:  Infect Immun       Date:  2010-05-10       Impact factor: 3.441

9.  Differential Mycobacterium bovis BCG vaccine-derived efficacy in C3Heb/FeJ and C3H/HeOuJ mice exposed to a clinical strain of Mycobacterium tuberculosis.

Authors:  Marcela Henao-Tamayo; Andrés Obregón-Henao; Elizabeth Creissen; Crystal Shanley; Ian Orme; Diane J Ordway
Journal:  Clin Vaccine Immunol       Date:  2014-11-12

10.  Live attenuated Salmonella vaccines displaying regulated delayed lysis and delayed antigen synthesis to confer protection against Mycobacterium tuberculosis.

Authors:  María Dolores Juárez-Rodríguez; Jiseon Yang; Rebin Kader; Praveen Alamuri; Roy Curtiss; Josephine E Clark-Curtiss
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.